Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
US10036017B2 · kind B2 · utility
3Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2016 |
| Grant date | Jul 31, 2018 |
| Priority date | — |
| Expiry date | Feb 16, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/11
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention relates to compounds, compositions, and methods useful for reducing C5 target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.